AWM Investment Company’s Black Diamond Therapeutics BDTX Stock Holding History

AWM Investment Company’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85M	Buy	1,000,000 +475,000	+90%	+$1.16M	0.16%	85
2026 Q1	$1.12M	Sell	525,000 -100,000	-16%	-$238K	0.12%	89
2025 Q4	$1.52M	Buy	625,000 +25,000	+4%	+$88.5K	0.15%	93
2025 Q3	$2.27M	Buy	600,000 +100,000	+20%	+$293K	0.21%	84
2025 Q2	$1.24M	Hold	500,000	–	–	0.14%	85
2025 Q1	$775K	Buy	+500,000	New	+$1.05M	0.11%	85

Other funds holding BDTX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

AWM Investment Company's BDTX Position: Q2 2026 in Review

AWM Investment Company increased its Black Diamond Therapeutics (BDTX) stake by 90% in Q2 2026, buying an estimated $1.16M and bringing the position to 1,000,000 shares worth $1.85M. The position accounts for 0.16% of the portfolio, ranked #85.

AWM Investment Company first reported a position in BDTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.27M in Q3 2025. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

AWM Investment Company held 1,000,000 shares of Black Diamond Therapeutics worth $1.85M as of Q2 2026.
AWM Investment Company bought 475,000 Black Diamond Therapeutics shares in Q2 2026, an estimated $1.16M.
Black Diamond Therapeutics made up 0.16% of AWM Investment Company's portfolio in Q2 2026, its #85 holding.
AWM Investment Company first reported a position in Black Diamond Therapeutics in Q1 2025 and has held it in 6 quarters since.
AWM Investment Company's Black Diamond Therapeutics position peaked at $2.27M in Q3 2025.
96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.